YS Biopharma (YS) has released an update.
YS Biopharma, a global biopharmaceutical player in vaccines and biologics for infectious diseases and cancer, has rebranded to LakeShore Biopharma. The move, reflecting their global market ambitions, will not impact shareholder rights or the company’s operations. Share trading under the new ticker symbols LSB and LSBPW will commence on May 28, 2024, on Nasdaq with no action required from shareholders.
For further insights into YS stock, check out TipRanks’ Stock Analysis page.
